In this region, Europe Drug Delivery Market is projected to reach USD 536.12 billion by 2024 from USD 305.54 billion in 2016, at a CAGR of 7.3% in the forecast period 2017 to 2024.
Based on geography, the Europe Drug Delivery market is segmented into 11 geographical regions, such as,

Germany,
France,
United Kingdom,
Italy,
Spain,
Russia,
Turkey,
Belgium,
Netherlands,
Switzerland and
Rest Of Europe.

Europe Drug Delivery market competition by top players including -
Johnson & Johnson is going to dominate the drug delivery market following with F. Hoffmann-La Roche Ltd and Novartis AG, along with others such as
Pfizer,
Bayer AG,
GlaxoSmithKline plc. ,
Merck & Co.,
Sanofi,
Antares Pharma,
3M,
Becton Dickinson and Company,
Nemera, Cima Labs, Inc.,
Dali Medical Devices,
Alkermes,
Foamis,
Ypsomed,
Skyepharma AG,
Valeant Pharmaceuticals
DSM Biomedical
Catalent, Inc.

The Europe drug delivery market is segmented on the basis of route administration, end user, and distribution channel.
The Europe drug delivery market is segmented into 8 types on the basis of route of administration, namely oral, injectable, topical, ophthalmic, nasal, pulmonary, implantable, transmucosal.
On the basis of end users, the market is classified into hospitals, clinics, home healthcare, community centres, and others.

On the basis of distribution channel, the market is segmented into direct tenders, hospital pharmacies, pharmacy stores, and online pharmacies.